Effective targeted treatment for hairy cell leukaemia

Friday, 26 February, 2016
An EU-funded project is conducting groundbreaking research into a rare form of leukaemia, proving the effectiveness in patients of non-chemotherapy-based treatments that target the genetic cause of the disease.

The Hairy Cell Leukemia project, launched by the Institute of Hematology at the University of Perugia in Italy with funding from the European Research Council, is one of the world’s foremost initiatives to develop a targeted therapy for hairy cell leukaemia (HCL), a rare form of blood cancer.

Read more

Rare Disease Day

Dr. Tiacci, University of Perugia, © E. Tiacci

See also: 
CORDIS
Project: 
Genetics-driven targeted therapy of Hairy Cell Leukemia
Project Acronym: 
HAIRY CELL LEUKEMIA
Project website: 
https://erc.europa.eu/
Article
Printer-friendly versionPDF version
#H2020